Immunogenicity and transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation

Pfs48/45 and Pfs25 are leading candidates for the development of Plasmodium falciparum transmission blocking vaccines (TBV). Expression of Pfs48/45 in the erythrocytic sexual stages and presentation to the immune system during infection in the human host also makes it ideal for natural boosting. How...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Datta, Dibyadyuti, Bansal, Geetha P., Gerloff, Dietlind L., Ellefsen, Barry, Hannaman, Drew, Kumar, Nirbhay
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5192010/
https://ncbi.nlm.nih.gov/pubmed/27912985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.11.072
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars